Stereotactic versus conventional radiotherapy for pain reduction and quality of life in spinal metastases: study protocol for a randomized controlled trial

Trials
Pètra BraamJohan Bussink

Abstract

Painful spinal metastases have been treated with conventional radiotherapy for decades, but one-third of the patients have insufficient pain relief after treatment and one-fifth need retreatment. Stereotactic radiotherapy is a method to increase the dose in the spinal metastases with a potentially longer lasting palliative effect without increasing the side effects of the treatment and thereby is expected to improve the quality of life significantly. This study is a multicenter prospective randomized clinical trial comparing conventional radiotherapy (1 x 8 Gy) with stereotactic radiotherapy (1 x 20 Gy) for pain reduction and quality of life in patients with painful spinal metastases. A total of 386 patients will be randomized between the two treatment groups. Besides pain measured by the Dutch Brief Pain Inventory, quality of life and cost-effectiveness also will be measured. The primary outcome is pain reduction at 6 weeks after treatment. Secondary outcomes will be the time to pain response, duration of pain relief, health-related quality of life and toxicity, as well as cost-effectiveness. This study investigates whether stereotactic radiotherapy with dose escalation for symptomatic spinal metastases can lead to improved pa...Continue Reading

References

Nov 30, 1999·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·E SteenlandT van Mierlo
May 18, 2004·International Journal of Radiation Oncology, Biology, Physics·Yvette M van der LindenUNKNOWN Dutch Bone Metastasis Study Group
Jun 2, 2005·Journal of the National Cancer Institute·William F HartsellMichelle DeSilvio
Sep 16, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Mogens GroenvoldUNKNOWN EORTC Quality of Life Group
Oct 11, 2005·Cancer·Peter C GersztenWilliam J Vogel
Mar 21, 2006·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Yvette M van der LindenUNKNOWN Dutch Bone Metastasis Study Group
Feb 1, 2008·International Journal of Radiation Oncology, Biology, Physics·Yoshiya YamadaZvi Fuks
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Edward ChowUNKNOWN EORTC Quality of Life Group
Sep 10, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter S RoseEric Lis
Jun 29, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daryl R FourneyCharles G Fisher
Aug 13, 2011·Cancer·Edward ChowUNKNOWN European Organization for Research Treatment of Cancer Quality of Life Group
Dec 3, 2011·American Journal of Clinical Oncology·Sheema ChawlaMichael T Milano
Feb 15, 2012·International Journal of Radiation Oncology, Biology, Physics·Kamran A AhmedNadia N Laack
Mar 8, 2012·Journal of Korean Neurosurgical Society·Seil Sohn, Chun Kee Chung
May 23, 2012·International Journal of Radiation Oncology, Biology, Physics·Brett W CoxYoshiya Yamada
Jan 17, 2013·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Kristopher DennisEdward Chow
Jul 3, 2013·The Lancet Oncology·Arjun SahgalMichael G Fehlings

❮ Previous
Next ❯

Citations

May 24, 2019·Journal of the National Cancer Institute·Katie L SpencerYvette M van der Linden

❮ Previous
Next ❯

Software Mentioned

OpenClinica

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.